Proteomic changes induced by histone demethylase JMJD3 in TNF alpha-treated human monocytic (THP-1) cells

Mol Immunol. 2013 Nov;56(1-2):113-22. doi: 10.1016/j.molimm.2013.04.013. Epub 2013 May 25.

Abstract

JMJD3, a Jumonji C family histone demethylase, plays an important role in the regulation of inflammation induced by the transcription factor nuclear factor-kappa B (NF-κB) in response to various stimuli. JMJD3 is a histone-3 lysine-27 trimethylation (H3K27me3) demethylase, a histone mark associated with transcriptional repression and activation of a diverse set of genes. The present study assessed stable JMJD3 knockdown (KD)-dependent proteomic profiling in human leukemia monocyte (THP-1) cells to analyze the JMJD3-mediated differential changes of marker expression in inflammatory cells. To analyze the protein expression profile of tumor necrosis factor-alpha (TNF-α)-stimulated JMJD3-kd THP-1 cells, we employed matrix-assisted-laser-desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS). Additionally, Ingenuity Pathways Analysis (IPA) was applied to establish the molecular networks. A comparative proteomic profile was determined in TNF-α-treated both of JMJD3-kd THP-1 cells and THP-1 scrambled (sc) cells. The expression of tripartite motif protein (TRIM5), glutathione peroxidase (GPx), glia maturation factor-γ (GMFG), caspase recruitment domain family, member 14 (CARMA2), and dUTP pyrophosphatase were significantly down-regulated, whereas heat shock protein beta-1 (HspB1) and prohibition were significantly up-regulated in JMJD3-kd THP-1 cells. The molecular and signaling networks of the differentially expressed proteins in JMJD3-kd THP-1 cells were determined by IPA. The molecular network signatures and functional proteomics obtained in this study may facilitate the suppression of different key inflammatory regulators through JMJD3-attenuation, which would be crucial to evaluate potential therapeutic targets and to elucidate the molecular mechanism of JMJD3-kd dependent effects in THP-1 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Restriction Factors
  • Blotting, Western
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism
  • Cell Line, Tumor
  • Electrophoresis, Gel, Two-Dimensional
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Jumonji Domain-Containing Histone Demethylases / genetics
  • Jumonji Domain-Containing Histone Demethylases / metabolism*
  • Monocytes / drug effects*
  • Monocytes / metabolism
  • Monocytes / pathology
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Proteome / genetics
  • Proteome / metabolism
  • Proteomics / methods*
  • RNA Interference
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / drug effects
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Tripartite Motif Proteins
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Ubiquitin-Protein Ligases

Substances

  • Antiviral Restriction Factors
  • Carrier Proteins
  • Cell Cycle Proteins
  • NUDC protein, human
  • Nuclear Proteins
  • Proteome
  • Tripartite Motif Proteins
  • Tumor Necrosis Factor-alpha
  • Jumonji Domain-Containing Histone Demethylases
  • KDM6B protein, human
  • TRIM5 protein, human
  • Ubiquitin-Protein Ligases